- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Oct 23, 2020 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Oct 26, 2020 | T-182-19 | T | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-1893-19 | T | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-2023-18 | T | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 8 d |
| Oct 26, 2020 | T-84-19 | T | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-978-19 | T | Janssen Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-1049-18 | CMC | Re/max, Llc V. Save Max Real Estate, Inc. Et Al. (Trade Mark) | Vancouver | 30 m |
| Oct 26, 2020 | T-2149-18 | M | Route1 Inc. V. Vmware,inc.,et Al (Patent) | Toronto | 2 h |
| Oct 26, 2020 | T-1623-16 | CMC | Eli Lilly Canada Inc. Et Al V. Pharmascience Inc. (Patent - Tadalafil*) | Ottawa | 1 h |
| Oct 26, 2020 | T-1627-16 | CMC | Eli Lilly Canada Inc. Et Al. V. Mylan Pharmaceuticals Ulc (Patent - Tadalafil*) | Ottawa | 1 h |
| Oct 26, 2020 | T-1631-16 | CMC | Eli Lilly Canada Inc. Et Al. V. Teva Canada Limited (Patent - Tadalafil*) | Ottawa | 1 h |
| Oct 26, 2020 | T-1632-16 | CMC | Eli Lilly Canada Inc., Eli Lilly And Company Et Al. V. Apotex Inc. (Patent - Tadalafil*) | Ottawa | 1 h |
| Oct 27, 2020 | T-1434-14 | M | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 1 d |
| Oct 27, 2020 | T-448-17 | T | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 2 d |
| Oct 28, 2020 | T-794-19 | TMC | Allergan Inc. Et Al V. Apotex Inc. (Patent - Risedronate*) | Toronto | 1 h |
| Oct 30, 2020 | T-2133-18 | CMC | Hockeyline Inc. V. Pointstreak Sports Technologies Inc. (Patent) | Toronto | 30 m |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Sep 14, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 17 d |
| Sep 28, 2020 | T-448-17 | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 14 d |
| Oct 6, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Ottawa | 4 d |
| Oct 13, 2020 | T-954-18 | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 13 d |
| Oct 13, 2020 | T-1069-14 | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 2 d |
| Oct 14, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 2 d |
| Oct 14, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 2 d |
| Oct 15, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 2 d |
| Oct 15, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 2 d |
| Oct 15, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 2 d |
| Oct 15, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 2 d |
| Oct 21, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 2 d |
| Oct 21, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 2 d |
| Oct 26, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 8 d |
| Oct 26, 2020 | T-1893-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-978-19 | Janssen Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-182-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-84-19 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 27, 2020 | T-448-17 | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 2 d |
| Nov 12, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 2 d |
| Nov 16, 2020 | T-227-17 | Dtechs Epm Ltd. V. British Columbia Hydro And Power Authority Et Al. (Patent) | Vancouver | 10 d |
| Nov 17, 2020 | T-168-18 | Lickerish, Ltd. V. Airg Inc. (Copyright) | Ottawa | 3 d |
| Nov 23, 2020 | T-917-17 | Sse Holdings, Llc Et Al V. Le Chic Shack Inc. (Trade Mark) | Québec | 5 d |
| Nov 30, 2020 | T-1158-18 | Maoz Betser-zilevitch V. Petrochina Canada Ltd. (Patent) | Toronto | 12 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Dec 3, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 14 d |
| Jan 11, 2021 | T-1948-16 | Upper Canada Forest Products Ltd V. Bramwood Forest Inc. (Trade Mark) | Toronto | 5 d |
| Jan 11, 2021 | T-708-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-706-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - PIRFENIDONE*) | Toronto | 10 d |
| Jan 11, 2021 | T-705-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-704-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Ottawa | 10 d |
| Jan 18, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Montréal | 40 d |
| Feb 1, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 5 d |
| Feb 1, 2021 | T-794-19 | Allergan Inc. Et Al V. Apotex Inc. (Patent - Risedronate*) | Toronto | 10 d |
| Feb 1, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 30 d |
| Feb 8, 2021 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Feb 15, 2021 | T-152-17 | Milano Pizza Ltd. V. 6034799 Canada Inc Et Al (Trade Mark) | Ottawa | 7 d |
| Feb 15, 2021 | T-1008-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-1007-19 | Hoffmann-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-943-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-942-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-941-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-939-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-899-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-898-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-897-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-896-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-770-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-768-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Mar 8, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 10 d |
| Mar 22, 2021 | T-1187-19 | Bayer Inc. And Other V. Dr. Reddy's Laboratories Ltd And Others (Patent - Rivaroxaban*) | Ottawa | 9 d |
| Mar 29, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 2 d |
| Apr 12, 2021 | T-1837-18 | Canplas Industries Ltd. V. Lomanco Inc. Et Al (Patent) | Toronto | 10 d |
| Apr 19, 2021 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 15 d |
| May 3, 2021 | T-123-15 | Bauer Hockey Corp. V. Sport Maska Inc. D.b.a. Ccm Hockey (Patent) | Ottawa | 38 d |
| Jun 14, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 13 d |
| Jun 14, 2021 | T-1749-19 | Searchlight Pharma Inc. C. Jamp Pharma Corporation (Patent - Darifenacin*) | Montréal | 8 d |
| Jun 28, 2021 | T-1749-19 | Searchlight Pharma Inc. C. Jamp Pharma Corporation (Patent - Darifenacin*) | Montréal | 2 d |
| Jul 5, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 2 d |
| Jul 19, 2021 | T-1642-16 | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Calgary | 10 d |
| Aug 30, 2021 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 15 d |
| Sep 1, 2021 | T-2072-19 | Boehringer Ingelheim (canada) Ltd. Et Al V. Teva Canada Limited (Patent - Aftinib*) | Toronto | 11 d |
| Sep 27, 2021 | T-454-20 | Bausch Health Ireland Ltd. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Efinaconazole*) | Toronto | 10 d |
| Oct 12, 2021 | T-28-20 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Saxagliptin*) | Toronto | 9 d |
| Oct 18, 2021 | T-34-20 | Amgen Inc. Et Al V. Purdue Pharma (Patent - Pegfilgrastim*) | Toronto | 10 d |
| Oct 18, 2021 | T-65-20 | Astellas Pharma Canada Inc. Et. Al. V. Sandoz Canada Inc. (Patent - Mirabegron*) | Toronto | 10 d |
| Oct 25, 2021 | T-1606-18 | Richards Packaging Inc. V. Distrimedic Inc (Patent) | Montréal | 15 d |
| Nov 1, 2021 | T-315-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| Nov 15, 2021 | T-353-20 | Celgene Inc. Et Al V. Natco Pharma (canada)inc. (Patent - Pomalidomide*) | Toronto | 15 d |
| Nov 15, 2021 | T-327-19 | Paypal, Inc. V. One 97 Communications Ltd. Et Al (Trade Mark) | Toronto | 12 d |
| Nov 16, 2021 | T-347-20 | Eisai Limited Et Al V. Taro Pharmaceuticals Inc. (Patent - Perampanel*) | Toronto | 11 d |
| Dec 2, 2021 | T-419-20 | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 2, 2021 | T-418-20 | Merck Sharp & Dohme Corp Et Al. V. Sandoz Canada Inc (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 6, 2021 | T-270-20 | Bayer Inc. Et Al V. Pharmascience Inc. (Patent) | Ottawa | 10 d |
| Jan 10, 2022 | T-453-20 | Bausch Health Ireland Ltd. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Efinaconazole*) | Toronto | 10 d |
| Jan 17, 2022 | T-511-20 | Celgene Inc. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent - Pomalidomide*) | Toronto | 10 d |
| Jan 17, 2022 | T-510-20 | Celgene Inc. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent - Pomalidomide*) | Toronto | 10 d |
| Jan 17, 2022 | T-1660-11 | Bernard Charles Sherman Et Al V. Pfizer Canada Inc., Et Al (Patent - Quinapril*) | Toronto | 10 d |
| Jan 17, 2022 | T-827-20 | Viiv Healthcare Company, Shionogi & Co., Ltd. Et Al. V. Sandoz Canada Inc. (Patent - DOLUTEGRAVIR*) | Toronto | 10 d |
| Jan 24, 2022 | T-549-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 7 d |
| Feb 7, 2022 | T-555-20 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Apixaban*) | Toronto | 5 d |
| Feb 14, 2022 | T-578-20 | Galderma Canada, Inc. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Adapalene*) | Toronto | 10 d |
| Feb 14, 2022 | T-649-20 | Hoffmann-la Roche Ltd Et Al. V. Teva Canada Ltd (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 14, 2022 | T-1935-13 | Bernard Charles Sherman Et Al V. Pharmascience Inc (Patent - Quinapril*) | Toronto | 10 d |
| Feb 28, 2022 | T-666-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-665-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-563-20 | Merck Sharp & Dohme Corp. Et Al V Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-561-20 | Merck Sharp & Dohme Corp. Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-560-20 | Merck Sharp& Dohme Corp Et Al V. Apotex Inc (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 14, 2022 | T-886-20 | Galderma Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Doxycycline*) | Toronto | 10 d |
| Mar 28, 2022 | T-798-20 | Opiant Pharmaceuticals Inc. Et Al V. Teva Canada Ltd. (Patent) | Toronto | 10 d |
| Mar 28, 2022 | T-667-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Apr 4, 2022 | T-769-20 | Janssen Inc. Et Al. V. Jamp Pharma Corporation (Patent - Macitentan*) | Toronto | 10 d |
| Apr 25, 2022 | T-671-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| Apr 25, 2022 | T-605-20 | Bayer Inc. Et Al. V. Mint Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Ottawa | 10 d |
| May 9, 2022 | T-989-20 | Janssen Inc. Et Al V. Jamp Pharma Corporation (unknown) | Toronto | 10 d |
| Jun 6, 2022 | T-891-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 10 d |
| Jul 4, 2022 | T-602-20 | Merck Sharp & Dohme Corp. Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-601-20 | Merck Sharp & Dohme Corp Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-673-20 | Merck Sharp & Dohme Corp. Et Al V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-670-20 | Merck Sharp & Dohme Corp, Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-668-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Oct 13, 2020 | T-1645-17 | Caterpillar Inc. V. Puma Se | Trade Mark Opposition | Toronto | 1 d |
| Oct 21, 2020 | T-870-20 | Fresenius Kabi Canada Ltd V. The Minister Of Health | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Oct 21, 2020 | T-1048-20 | Fresenius Kabi Canada Ltd. V. The Minister Of Health - Adalimumab* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Dec 7, 2020 | T-984-20 | Catalyst Pharmaceuticals Inc. Et Al V. Agc Et Al | S. 18.1 Application for Judicial Review | Ottawa | 1 d |
| Dec 10, 2020 | T-189-19 | Preventous Collaborative Health V. Canada (minister Of Health) | S. 18.1 Application for Judicial Review | Calgary | 1 d |
| Dec 10, 2020 | T-190-19 | Provital Health V. Canada (minister Of Health) | S. 18.1 Application for Judicial Review | Calgary | 1 d |
| Dec 10, 2020 | T-191-19 | Copeman Healthcare Centre V. Canada (minister Of Health) | S. 18.1 Application for Judicial Review | Calgary | 1 d |
| Feb 11, 2021 | T-1663-19 | Canadian Broadcasting Corp. Et Al. V. Conservative Party Of Canada Et Al. | Copyright Infringement [Applications] | Toronto | 1.3 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Nov 2, 2020 | A-356-19 | Group Iii International Ltd Et Al V. Travelway Group International Ltd | Appeal (S.27 - Final) - Trade-marks Act [from T-1380-13 - S. 18.1 Application for Judicial Review] | Ottawa | 3 h |
| Nov 3, 2020 | A-408-19 | Canmar Foods Ltd. V. Ta Foods Ltd. | Appeal (S.27 - Final) - Others [from T-2138-18 - Patent Infringement] | Ottawa | 4 h |
| Nov 3, 2020 | A-122-20 | Amgen Inc. Et Al. V. Pfizer Canada Ulc | Appeal (S.27 - Final) - Patent Act | Toronto | 1 d |
| Nov 4, 2020 | A-149-20 | Arctic Cat, Inc V. Bombardier Recreational Products | Appeal (S.27 - Final) - Patent Act [from T-2025-11 - Patent Infringement] | Ottawa | 1 d |
| Nov 5, 2020 | A-397-19 | Hospira Healthcare Corp. V. The Kennedy Trust Rheumatology Research - Infliximab* | Appeal (S.27 - Interloc.) - Patent Act [from T-396-13 - Patent Impeachment] | Toronto | 3 h |
| Nov 5, 2020 | A-396-19 | Hospira Healthcare Corp. Et Al V. Kennedy Trust For Rheumatology Res. Et Al - Infliximab* | Appeal (S.27 - Interloc.) - Patent Act [from T-396-13 - Patent Impeachment] | Toronto | 3 h |
| Nov 23, 2020 | A-139-19 | Tensar Technologies, Limited Et Al. V. Enviro-pro Geosynthetics, Ltd. | Appeal (S.27 - Final) - Statutory Appeal [from T-1930-13 - Patent Infringement] | Ottawa | 3 h |
| Nov 24, 2020 | A-139-19 | Tensar Technologies, Limited Et Al. V. Enviro-pro Geosynthetics, Ltd. | Appeal (S.27 - Final) - Statutory Appeal [from T-1930-13 - Patent Infringement] | Ottawa | 3 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.